妊娠期诊断宫颈癌的管理与结局
该回顾性研究分析了1997年至2013年间28例妊娠期诊断宫颈癌患者,并与同期同年龄同分期的非妊娠患者1:2匹配比较。妊娠组治疗时间显著更长(20.8 vs 7.9周,P=0.0014),但两组生存无显著差异(89.3% vs 95.2%,P=0.08)。妊娠期根治性子宫切除术估计出血量显著高于产后组(2033 vs 425 mL,P=0.0064)。
要点
- 妊娠期宫颈癌诊断时的孕周是管理决策的重要决定因素,25%(7/28)终止妊娠者诊断孕周更早(10.9 vs 19.7周,P=0.006)。
- 继续妊娠者平均分娩孕周为36.1周,妊娠并发症不常见。
- 妊娠组治疗时间显著长于非妊娠组(20.8 vs 7.9周,P=0.0014),但生存无显著差异(89.3% vs 95.2%,P=0.08)。
核心结论
- 诊断时孕周是妊娠期宫颈癌管理的重要决定因素,需及时处理异常宫颈细胞学检查。
- 继续妊娠者多数在晚早产期分娩,无显著产科并发症。
- 围产期行根治性子宫切除术的并发症率与非妊娠患者相似。
- 死亡患者更可能在诊断时即为晚期疾病。
研究设计与样本
- 回顾性病历审查,纳入1997年至2013年妊娠期诊断宫颈癌患者28例,按1:2匹配同期同年龄同分期的非妊娠宫颈癌患者。
- 通过国际疾病分类第九版编码和Dana-Farber/马萨诸塞州总医院癌症登记处识别患者。
- 数据分析使用Stata 10.1版(College Station, TX)。
主要发现
- 28例妊娠期诊断宫颈癌患者中,多数为IB1期。
- 25%(7/28)终止妊娠,终止妊娠者诊断孕周更早(10.9 vs 19.7周,P=0.006)。
- 未终止妊娠者平均分娩孕周为36.1周,妊娠并发症不常见。
- 妊娠组治疗时间显著长于非妊娠组(20.8 vs 7.9周,P=0.0014),但两组生存无显著差异(89.3% vs 95.2%,P=0.08)。
- 妊娠期行根治性子宫切除术者估计出血量显著高于产后行根治性子宫切除术者(2033 vs 425 mL,P=0.0064),其他手术特征相似。
临床怎么用
- 诊断时孕周是妊娠期宫颈癌管理的重要决定因素,需及时处理异常宫颈细胞学检查。
- 继续妊娠者多数在晚早产期分娩,无显著产科并发症。
- 围产期行根治性子宫切除术的并发症率与非妊娠患者相似。
- 该信息可能有助于为面临妊娠期宫颈癌诊断的女性提供咨询。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cervical cancer is the third most common gynecologic malignancy in the United States. Approximately 1-3% of cervical cancers will be diagnosed in pregnant and peripartum women; optimal management in the setting of pregnancy is not always clear. OBJECTIVE: We sought to describe the management of patients with cervical cancer diagnosed in pregnancy and compare their outcomes to nonpregnant women with similar baseline characteristics. STUDY DESIGN: We conducted a retrospective chart review of all patients diagnosed with cervical cancer in pregnancy and matched them 1:2 with contemporaneous nonpregnant women of the same age diagnosed with cervical cancer of the same stage. Patients were identified using International Classification of Diseases, Ninth Revision codes and the Dana-Farber/Massachusetts General Hospital Cancer Registry. Data were analyzed using Stata, Version 10.1 (College Station, TX). RESULTS: In all, 28 women diagnosed with cervical cancer during pregnancy were identified from 1997 through 2013. The majority were Stage IB1. In all, 25% (7/28) of women terminated the pregnancy; these women were more likely to be diagnosed earlier in pregnancy (10.9 vs 19.7 weeks, P = .006). For those who did not terminate, mean gestational age at delivery was 36.1 weeks. Pregnancy complications were uncommon. Complication rates in pregnant women undergoing radical hysterectomy were similar to those outside of pregnancy. Time to treatment was significantly longer for pregnant women compared to nonpregnant patients (20.8 vs 7.9 weeks, P = .0014) but there was no survival difference between groups (89.3% vs 95.2%, P = .08). Women who underwent gravid radical hysterectomy had significantly higher estimated blood loss than those who had a radical hysterectomy in the postpartum period (2033 vs 425 mL, P = .0064), but operative characteristics were otherwise similar. None of the pregnant women who died delayed treatment due to pregnancy. CONCLUSION: Gestational age at diagnosis is an important determinant of management of cervical cancer in pregnancy, underscoring the need for expeditious workup of abnormal cervical cytology. Of women who choose to continue the pregnancy, most delivered in the late preterm period without significant obstetric complications. For women undergoing radical hysterectomy in the peripartum period, complication rates are similar to nonpregnant women undergoing this procedure. Women who died were more likely to have advanced stage disease at the time of diagnosis. This information may be useful in counseling women facing the diagnosis of cervical cancer in pregnancy.
引用
- Bigelow CA, Horowitz NS, Goodman A, et al. Management and outcome of cervical cancer diagnosed in pregnancy. Am J Obstet Gynecol. 2016. PMID: 27810552. doi:10.1016/j.ajog.2016.10.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。